In contrast, patient EP17, BRAF p.Val600Glu negative in clinical testing, exhibited positivity solely in the whole‐tumour section, including both the selected regions and interstitial regions not associated with a specific morphological type. This evidence concerns the gene BRAF and neoplasm.